BD Accelerates Advanced Tissue Regeneration Strategy with Landmark PREVENT Trial
Enrollment completed in the first large-scale randomized study evaluating Phasix™ Mesh for incisional hernia prevention, a significant unmet need following abdominal surgery FRANKLIN LAKES, N.J., Aug. 12, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading...
Covered in this story
What has happened since
- Becton Dickinson is up 5.6% since this was published, 69 days ago.
Price move measured from the close nearest publication to the latest quote.
Call it yourself
No calls on $BDX yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Becton Dickinson →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.